Burney Company’s Anavex Life Sciences AVXL Stock Holding History

Burney Company’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,000	Closed	-$32K	–	413
2017 Q4	$32K	Buy	+10,000	New	+$39.4K	﹤0.01%	437

Other funds holding AVXL

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Burney Company's AVXL Position: Q1 2018 in Review

Burney Company sold out of Anavex Life Sciences (AVXL) in Q1 2018, closing a stake of 10,000 shares — an estimated $32K sold.

Burney Company first reported a position in AVXL in Q4 2017 and held it in 1 quarter. The position peaked at $32K in Q4 2017. 58 funds tracked by Wall St. Rank hold AVXL as of Q1 2018.

Burney Company reported no remaining Anavex Life Sciences position as of Q1 2018 after selling out during the quarter.
Burney Company sold 10,000 Anavex Life Sciences shares in Q1 2018, an estimated $32K.
Burney Company first reported a position in Anavex Life Sciences in Q4 2017 and held it in 1 quarter.
Burney Company's Anavex Life Sciences position peaked at $32K in Q4 2017.
58 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2018.

Based on Burney Company's 13F filing for Q1 2018, filed 8 May 2018.